Imran Raza Mirza

Dr. Imran Raza Mirza

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
IMImran Raza Mirza
Imran Raza Mirza
ELEphrem Tekle Lemango
Ephrem Tekle Lemango
ALAnn Lindstrand
Ann Lindstrand
Throughout history, disease and epidemics have shaped human survival

19 February 2020 in BMC Public Health
Verified
Journal Article
Open access
PDF file
SNSylvain F. Nkwenkeu
Sylvain F. Nkwenkeu
MJMohamed F. Jalloh
Mohamed F. Jalloh
JWJenny A. Walldorf
Jenny A. Walldorf
RZRobert L. Zoma
Robert L. Zoma
FTFelix Tarbangdo
Felix Tarbangdo
IMImran Raza Mirza
Imran Raza Mirza
Background: Meningococcal serogroup A conjugate vaccine (MACV) was introduced in 2017 into the routine childhood immunization schedule (at 15–18 months of age) in Burkina Faso to help reduce meningococcal meningitis burden. MACV was scheduled to be co-administered with the second dose of measles-containing vaccine (MCV2), a vaccine already in the national schedule. One year following the introduction of MACV, an assessment was conducted to qualitatively examine health workers’ perceptions of MACV introduction, identify barriers to uptake, and explore opportunities to improve coverage. Methods: Twelve in-depth interviews were conducted with different cadres of health workers in four purposively selected districts in Burkina Faso. Districts were selected to include urban and rural areas as well as high and low MCV2 coverage areas. Respondents included health workers at the following levels: regional health managers (n = 4), district health managers (n = 4), and frontline healthcare providers (n = 4). All interviews were recorded, transcribed, and thematically analyzed using qualitative content analysis. Results: Four themes emerged around supply and health systems barriers, demand-related barriers, specific challenges related to MACV and MCV2 co-administration, and motivations and efforts to improve vaccination coverage. Supply and health systems barriers included aging cold chain equipment, staff shortages, overworked and poorly trained staff, insufficient supplies and financial resources, and challenges with implementing community outreach activities. Health workers largely viewed MACV introduction as a source of motivation for caregivers to bring their children for the 15- to 18-month visit. However, they also pointed to demand barriers, including cultural practices that sometimes discourage vaccination, misconceptions about vaccines, and religious beliefs. Challenges in co-administering MACV and MCV2 were mainly related to reluctance among health workers to open multi-dose vials unless enough children were present to avoid wastage. Conclusions: To improve effective administration of vaccines in the second-year of life, adequate operational and programmatic planning, training, communication, and monitoring are necessary. Moreover, clear policy communication is needed to help ensure that health workers do not refrain from opening multi-dose vials for small numbers of children.

25 November 2022 in Lung Cancer
Verified
Journal Article
Closed access
DBDarren R. Brenner
Darren R. Brenner
DODylan O'Sullivan
Dylan O'Sullivan
TJTamer N. Jarada
Tamer N. Jarada
AYAmman Yusuf
Amman Yusuf
DBDevon Boyne
Devon Boyne
IMImran Raza Mirza
Imran Raza Mirza

27 December 2023 in Global Health: Science and Practice
Verified
Journal Article
Open access
PDF file
IMImran Raza Mirza
Imran Raza Mirza
IAIda-Marie Ameda
Ida-Marie Ameda
ABAntoinette Eleonore Ba
Antoinette Eleonore Ba
CTCelestin Traore
Celestin Traore
MHMekonnen Tadesse Hagos
Mekonnen Tadesse Hagos
BSBenjamin Schreiber
Benjamin Schreiber
Key Messages Despite pandemic-related challenges, COVID-19 vaccination illuminated opportunities to strengthen primary health care, including community-based health systems, establish a platform for future adult vaccination, and inform pandemic preparedness efforts. Integration is multifaceted and multisectoral, requiring an understanding of the existing health system architecture, resources, and constraints, and can be achieved by leveraging partnerships, collaborations, and existing infrastructure. Including demand and awareness-generating activities and using varied communication strategies is essential for addressing hesitancy and tackling concerns and fears.


12 December 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
AAAdidja AMANI
Adidja AMANI
EDEkra Kouadio Daniel
Ekra Kouadio Daniel
BGBrou Gbotto
Brou Gbotto
KYKossia Yao
Kossia Yao
ANAka Lépri Nicaise
Aka Lépri Nicaise
BSBenjamin Schreiber
Benjamin Schreiber
Introduction: With the containment of the COVID-19 pandemic in Côte d’Ivoire, efforts were made to seamlessly integrate COVID-19 vaccination into the national immunization program. A collaborative initiative involving UNICEF, WHO, GAVI, and partner organizations resulted in the creation of the COVID-19 Vaccine Integration Mapping Tool. This paper presents a case study documenting the field testing of the integration mapping tool and assessing the integration of COVID-19 vaccination within primary healthcare and routine immunization in Côte d’Ivoire. The study aims to describe the pilot process, gather feedback on tool usefulness and challenges, and establish integration priorities through roadmap development. Methods: Under the guidance of the Ministry of Health and Universal Coverage Cabinet, a workshop was conducted with participants from major health programs to field test the tool. Data analysis was performed using Excel, and the results were presented through tables, heat maps, and line graphs. Results: The first-of-its-kind field test of the integration mapping tool in Côte d’Ivoire showcased its potential to bring key partners together to discuss the current state of integration, improve transparency about resource allocation, and enhance data management for the incorporation of COVID-19 vaccination into existing immunization systems. The integration of COVID-19 vaccines in Côte d’Ivoire showed a moderate level of progress, with improvement needed in resource allocation, payment systems, targeting of highest-risk groups and vaccine administration. Support should be increased for target population identification, distribution points, quality of care mechanisms, and health personnel training. Health information systems and access to essential medicines were relatively satisfactory. Integration into existing programs, intersectoral collaboration, national health strategy, communication strategy, community participation, and data utilization require improvement. The post-workshop satisfaction survey gave the tool a score of 7 out of 10. Early lessons from Côte d’Ivoire provide guidance on enhancing integration, focusing on data-driven decision-making, collaboration, stakeholder engagement, and effective leadership. Conclusions: The field test of the integration mapping tool (IMT) in Côte d’Ivoire is groundbreaking as it exemplifies the transformative potential of innovative tools in immunization practices. Application of the IMT sets a precedent for seamless COVID-19 vaccination integration worldwide, emphasizing data-driven decision-making, collaboration, timing, and leadership. The success of the pilot exercise in Côte d’Ivoire was attributed to political commitment, well-facilitated workshops, assessments, and the fact that the team in the country had previously developed an initial integration plan.